[go: up one dir, main page]

TR201009165A2 - Tablets containing cefdinir - Google Patents

Tablets containing cefdinir

Info

Publication number
TR201009165A2
TR201009165A2 TR2010/09165A TR201009165A TR201009165A2 TR 201009165 A2 TR201009165 A2 TR 201009165A2 TR 2010/09165 A TR2010/09165 A TR 2010/09165A TR 201009165 A TR201009165 A TR 201009165A TR 201009165 A2 TR201009165 A2 TR 201009165A2
Authority
TR
Turkey
Prior art keywords
tablets containing
cefdinir
containing cefdinir
compositions
manufacture
Prior art date
Application number
TR2010/09165A
Other languages
Turkish (tr)
Inventor
Bi̇lgi̇ç Mahmut
Original Assignee
Bi̇lgi̇ç Mahmut
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bi̇lgi̇ç Mahmut filed Critical Bi̇lgi̇ç Mahmut
Priority to TR2010/09165A priority Critical patent/TR201009165A2/en
Priority to TR2010/10859A priority patent/TR201010859A2/en
Priority to PCT/TR2011/000252 priority patent/WO2012060787A1/en
Priority to PCT/TR2011/000257 priority patent/WO2012060792A1/en
Publication of TR201009165A2 publication Critical patent/TR201009165A2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A61K31/546—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine containing further heterocyclic rings, e.g. cephalothin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Cephalosporin Compounds (AREA)

Abstract

Mevcut buluş, aktif ajan olarak sefdinir içeren farmasötik bileşimlere ve bu bileşimlerin hazırlanmasında kullanılacak bir üretim yöntemine ilişkindir.The present invention relates to pharmaceutical compositions comprising cefdinir as the active agent and a method of manufacture for the preparation of such compositions.

TR2010/09165A 2010-11-05 2010-11-05 Tablets containing cefdinir TR201009165A2 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
TR2010/09165A TR201009165A2 (en) 2010-11-05 2010-11-05 Tablets containing cefdinir
TR2010/10859A TR201010859A2 (en) 2010-11-05 2010-12-24 Tablet forms containing cefdinir.
PCT/TR2011/000252 WO2012060787A1 (en) 2010-11-05 2011-11-03 Oral dosage forms comprising cefdinir and carboxymethyl cellulose calcium
PCT/TR2011/000257 WO2012060792A1 (en) 2010-11-05 2011-11-03 Pharmaceutical compositions comprising minimum 6 % of disintegrants by weight

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TR2010/09165A TR201009165A2 (en) 2010-11-05 2010-11-05 Tablets containing cefdinir

Publications (1)

Publication Number Publication Date
TR201009165A2 true TR201009165A2 (en) 2012-05-21

Family

ID=45418748

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2010/09165A TR201009165A2 (en) 2010-11-05 2010-11-05 Tablets containing cefdinir

Country Status (2)

Country Link
TR (1) TR201009165A2 (en)
WO (1) WO2012060792A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102019125872A1 (en) 2019-09-25 2021-03-25 Schaeffler Technologies AG & Co. KG Hybrid powertrain

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA836918B (en) 1982-09-30 1984-05-30 Fujisawa Pharmaceutical Co 7-substituted-3-vinyl-3-cephem compounds and processes for the production of the same
US20090197855A1 (en) * 2006-05-01 2009-08-06 Makarand Krishnakumar Avachat Pharmaceutical compositions of cefdinir
TR201001417A1 (en) * 2010-02-25 2011-09-21 Sanovel İlaç San. Ve Ti̇c. A. Ş. Cefdinir formulation with improved dissolution rate

Also Published As

Publication number Publication date
WO2012060792A1 (en) 2012-05-10

Similar Documents

Publication Publication Date Title
JOP20180103A1 (en) Pharmaceutical composition
EA201300146A1 (en) PHARMACEUTICAL COMPOSITIONS OF C-MET MODULATOR
UA111717C2 (en) ORAL INTRODUCTION AND METHYLNALTREXON LIPOPHILIC SALTS
EA201300388A1 (en) COMPOUNDS OF SUBSTITUTED BENZAMIDE
EA201590887A1 (en) COMPOSITION
EA201200616A1 (en) DERIVATIVES 2-OXO-1-PIRROLIDININILIMIDAZOTHIAADIA ASOL
MY166449A (en) Pharmaceutical composition of rosuvastatin calcium
EA201291211A1 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING HYDROMORPHONE AND NALOXONE
UA116889C2 (en) COMPOSITION COMPRISING A MIXTURE OF CD95-Fc ISOFORMS
EA201590787A1 (en) SUBSTITUTED PYRIDOPYRAZINES AS SYK INHIBITORS
TR201903918T4 (en) Compositions containing a dispersing agent and their preparation.
MX353618B (en) Solid pharmaceutical preparation containing levothyroxine.
TN2013000386A1 (en) Suspension type topical formulations comprising cyclic depsipeptide
TR201009167A2 (en) Pharmaceutical granules containing cephalosporin.
MX2014004210A (en) 2-oxo-piperidinyl derivatives.
CO6680629A2 (en) Compounds with antibacterial activity against clsotridium
TR200909785A1 (en) Pharmaceutical compositions containing cefdinir as the active agent.
TR201010859A2 (en) Tablet forms containing cefdinir.
TR201011148A1 (en) Levetiracetam pharmaceutical compositions.
EP2568810A4 (en) Darunavir compositions
TR200906506A2 (en) Solid dosage forms containing telmisartan.
EA201500313A1 (en) STABILIZED AMORPHOUS FORM OF AGOMELATIN, THE WAY OF ITS MANUFACTURE AND PHARMACEUTICAL COMPOSITIONS, ITS CONTAINING
TR201009165A2 (en) Tablets containing cefdinir
TR201009166A2 (en) Production method for cefdinir-containing pharmaceutical composition
TR201109160A2 (en) New pharmaceutical compositions containing eplerenone.